Cellerix
Madrid, Madrid, Spain
About Cellerix
Cellerix, S.A., a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa. Cellerix, S.A. was founded in 2004 and is based in Tres Cantos, Spain.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $115.3M
- Funding stage: M&A
- Last round: Series C (Jan 2010)
- Website: cellerix.com
- Phone: +34 91 804 92 64
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cellerix-2525640 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.